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Free or resin-bound peptides were phosphorylated at their N-termini by reacting with
dimethyl phosphite in the presence of tetrachloromethane and triethylamine, and some of
them were labeled using partial deuterium-labeled dimethyl phosphites (molar ratio of m 
6 and m  1:1 or m  6, m  3 and m  1:2:1) as the phosphorylating agents. The
monophosphorylation of the lysine-containing peptides selectively occurred on the amino
group of the N-terminus, not the side-chain of lysine residue. The resin-bound phosphorami-
date peptides were cleaved by TFA before ESI-MS. The modified peptides were determined by
electrospray ionization mass spectrometry, the protonated molecules of the unlabeled phos-
phoramidate peptides showed the singlet peaks, and those of the labeled phosphoramidate
peptides displayed the doublet and/or triplet peaks. Tandem mass spectra (MS/MS) of the
chosen protonated molecules gave sequential loss of the amino acid residues from the
C-termini of the peptides, providing a convenient and rapid method for peptide
sequencing. (J Am Soc Mass Spectrom 2006, 17, 995–999) © 2006 American Society for Mass
SpectrometryRapid and convenient peptide sequencing ishighly desirable in proteomics and related bio-science. While the conventional method, Edman
sequencing, does not fulfill this task, tandem mass
spectrometry (MS/MS) provides a means for rapid
identification and characterization of peptides/proteins
[1–5]. Unfortunately, a protonated peptide is typically
dissociated into a wide variety of N-terminal and C-
terminal fragment ions. In general, it is difficult to
predict which type of fragment ions will be formed for
a single charged peptide, and the MS/MS spectra are
often so complicated that de novo sequence determina-
tion is impossible. Many efforts have been made to
enhance the response sensitivity and simplify mass
spectra by modifying peptides. Positive [5–7] and neg-
ative [8] ion derivatization of peptides are two usual
methods. In the previous research from our laboratory,
it was found that the response sensitivity in positive ion
FAB-MS [9] could be improved greatly by introducing a
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group to N-termini of peptides. The dissociation effi-
ciency seemed to be higher in this case; unfortunately, a
variety of dissociation pathways of the phosphoryl
group complicated the mass spectra and sequence in-
terpretation due to successive loss of two alkenes. In
this paper, various free or resin-bound peptides were
phosphorylated into phosphoramidate peptides using
unlabeled and labeled dimethyl phosphites as phos-
phorylating agents, and the modified peptides were
analyzed by ESI-MS, and tandem mass spectra (ESI-
MS/MS) of their protonated molecules showed unam-
biguously amino acid residue sequences of the original
peptides.
Experimental
Materials
The Wang and Rink resin-bound protected peptides
(10 mg of peptides on 500 mg of resin) were pur-
chased from Glsynthesis Company (Shanghai, China).
They are H-Val-Glu(OtBu)-Gln(trt)-His(trt)-Wang Resin
(VEQH, loading 0.6 mmol/g), H-Ala-Lys(Boc)-Asp
(OtBu)-Leu-Wang Resin (AKDL, loading 0.6 mmol/g),
H-Val-Tyr(tBu)-Lys(Boc)-Asp(OtBu)-His(trt)-Wang Resin
(VYKDH, loading 0.56 mmol/g), H-Ala-Arg(Pbf)-Leu-
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996 WANG ET AL. J Am Soc Mass Spectrom 2006, 17, 995–999Val-Glu(OtBu)-Wang resin (ARLVE, loading 0.62 mmol/g),
H-Ala-Lys(Boc)-Asp(OtBu)-Trp(Boc)-Val-Rink Amide-AM
Resin (AKDWV, loading 0.7 mmol/g), and H-Leu-Pro-Asp-
(OtBu)-Ser(tBu)-Phe-Ala-Rink Amide-AM Resin (LPDSFA,
loading 0.7 mmol/g). Other chemicals were purchased from
Aldrich (Shanghai, China).
Synthesis of the Phosphorylating Reagents
Dimethyl phosphite (DMP-H, 1), deuterium-labeling
dimethyl phosphite (D6-DMP-D, 2), and partial deuterium-
labeling dimethyl phosphite mixture (DMP132-X)
(Scheme 1) were prepared according to the known
procedure [10]. DMP12-X was obtained by mixing one
equivalent each of dimethyl phosphite (DMP-H) and
deuterium-labeling dimethyl phosphite (D6-DMP-D).
DMP132-X was prepared as follows: the mixed solution
of methanol (24 mmol) and deuterium-labeling metha-
nol (24 mmol) in 5 mL of dry CH2Cl2 was added
dropwise to PCl3 (8 mmol) in 5 mL of dry CH2Cl2 at
0 °C under nitrogen atmosphere. The solution was
warmed to room temperature and stirred for 30 min,
and 31P NMR spectroscopy showed that PCl3 almost
quantitatively transferred into DMP132-X. The crude
sample was obtained after distillation of gaseous HCl
and CH2Cl2, and it was used without further purifica-
tion (1H NMR showed that the purity was more than
98%). 31P NMR of the three phosphorylating reagents:
12.5 ppm.
Two Methods for Synthesis of Phosphoramidate
Peptides
Method A: 1 mg of peptide-bound resin (2000 beads)
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Scheme 1. Three phosphorylating reagents and the synthetic
route for phosphoramidate peptides.was added to a 1.5 mL microcentrifuge tube, 100 L oftrifluoroacetic acid (TFA) was added, and the peptide
was cleaved from theWang or Rink resin within 30 min.
TFA was removed with N2, and 10 L (72 mol) of
triethylamine, 20 L (0.21 mmol) of tetrachloromethane,
960 L of methanol and 10 L (90 mol) of phosphor-
ylating regent were added to the microcentrifuge tube
containing the peptide at 0 °C. The microcentrifuge tube
was shaken for 2 h at this temperature, the tube was
centrifuged, and 10 L (0.6 nmol/L) of the clear
solution was drawn off and diluted with 990 L of
methanol containing 0.05% TFA, and 40 L (6 pmol/
L, 240 pmol) of the resulting mixture was directly
used to analyze by ESI mass spectrometry.
Method B: 1 mg of bound-peptide resin was put to a
1.5 mL microcentrifuge tube, and then 100 L (720
mol) of Et3N, 100 L (1.04 mmol) of CCl4, 400 L of
methanol, 15 L (130 mol) of phosphorylating re-
gent were added to the microcentrifuge tube at 0 °C.
The tube was shaken for 4 h at this temperature, the
solution was removed by filtration, and the peptide-
bound resin was washed with methanol (3  0.5 mL).
About 15 beads (4.5 nmol of the modified peptide)
were picked out and put to a 1.5 mL microcentrifuge
tube, and 100 L of TFA was added to the tube. After 30
min, TFA was removed with N2, the residue was
dissolved in 1 ml of methanol containing 0.05% TFA,
and 40 L (4.5 pmol/L, 180 pmol) of the solution
containing the phosphoramidate peptide was peptide
was analyzed by ESI mass spectrometry.
Mass Spectrometric Conditions
Electrospray ionization mass spectra were acquired on
a Bruker ESQURE-LC ion trap spectrometer (Billerica,
MA) equipped with a gas nebulizer probe. All experi-
ments were carried out in the positive ionization mode.
Nitrogen was used as drying gas with flow rate 4 or 8
L/min. The nebulizer pressure was 7 or 11 psi. The
applied voltage on the electrospray needle was typi-
cally held at 4 kV and the capillary temperature was
maintained at 300 °C for all samples. Forty L of the
phosphoramidate peptide solution was injected into the
ESI source at a flow rate of 4 L/min. The number of
overlap spectrumwas 5. Selected ions were analyzed by
multistage tandem mass spectrometry using helium as
collision gas.
Results and Discussion
Preparation of Dimethyl Phosphite
and the Phosphoramidate Peptides
Reaction of PCl3 with three equivalents of CH3OH in
CH2Cl2 gave dimethyl phosphite (1, DMP-H), the cor-
responding deuterium-labeling dimethyl phosphite (2)
was obtained when three equivalents of CD3OD was
used instead of CH3OH in the reaction and a mixture of
1 and 2 (1:1) gave DMP12-X. Reaction of PCl3 with 1.5
equivalents of CH3OH and 1.5 equivalents of CD3OD
997J Am Soc Mass Spectrom 2006, 17, 995–999 N-TERMINAL PHOSPHORYLATION AND ESI-MSyielded DMP132-X (Scheme 1). Reaction of the three
reagents with peptides gave the corresponding phos-
phoramidate peptides.
Phosphorylation of the Free Peptides
and Peptide Sequencing
Reaction mixtures obtained by method A (see the
Experimental section) were analyzed directly. For ex-
ample, the primary ESI-MS spectrum (Figure 1a) of
phosphoramidate peptide DMP-VYKDH-OH cleaved
from Wang-resin shows the protonated molecule [M 
H] at m/z 769, the protonated diphosphorylated prod-
uct at m/z 877 was also observed due to the presence of
a Lys residue. The protonated monophosphorylated
peptide at m/z 769 was selected for MS/MS analysis
(Figure 1b). The bn-type ions (m/z 614,499, 371) were
observed together with a2-ion at m/z 343. ESI-MS
3 of the
a2-ion produced the b1-ion at m/z 208 (Figure 1c),
allowing the phosphoramidate peptide to be easily
sequenced as DMP-VYKDH-OH. Interestingly, the in-
tense fragment ions in Figure 1b all contain a phospho-
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Figure 1. (a) ESI-MS spectrum of DMP-VYKDH-OH. (b) ESI-MS2
spectrum of the protonated molecule [M  H] at m/z 769 in
Figure 1a. (c) ESI-MS3 spectrum of a2-ion at m/z 343 in Figure 1b.
(d) ESI-MS2 spectrum of the protonated molecule [MH] at m/z
725 of DMP-AKDWV-NH2.ryl group on the amino group of the N-terminus andnot the lysine side-chain, showing that monophospho-
rylation selectively occurred on the N-terminal amino
group of the original peptide under the phosphorylat-
ing conditions described above. In fact, similar exam-
ples of selective N-terminal modification for peptides
containing lysine residue have been found using S-
pentafluorophenyl [tris(2,4,6-trimethoxyphenyl)phos-
phonium]acetate bromide [6] and 5-bromonicotinic acid
N-hydroxysuccinimide ester [11] as the modifying re-
agents by Watson et al. and Tsunasawa and coworkers,
respectively.
We also sequenced the phosphoramidate peptides
containing a C-terminal amide group using a similar
procedure. For example, the primary ESI-MS spectrum
of DMP-AKDWV-NH2 showed the protonated mole-
cule [M  H] at m/z 725 and the protonated diphos-
phorylated peptide at m/z 833.ESI-MS2 (Figure 1d) of
the protonated molecule [M  H] at m/z 725 produced
the bn-type ions at m/z 609, 423, 308, and ESI-MS
3 of
b2-ion at m/z 308 in Figure 1d yielded the b1-ion at m/z
180. Therefore, the complete amino acid sequence of the
phosphoramidate peptide was determined as DMP-
AKDWV-NH2. It was, however, difficult to identify
quickly the protonated phosphoramidate peptides due
to the presence of impurities in the spectra.
Labeling of Free Peptides via Phosphorylation
and Peptide Sequencing
We overcame this problem with a labeling method
involving phosphorylation of the free peptides with
partial deuterium-labeled dimethyl phosphite (DMP12-X
or DMP132-X) (Scheme 1). The protonated molecules of
the monophosphorylated peptides showed doublet or
triplet peaks due to isotopic labeling, and the diphos-
phorylated peptides on the amino groups of both the
N-terminus and side-chain of Lys residue displayed
multiple peaks. The non-peptide impurities showed
singlet peaks because they lacked amino group and
could not be phosphorylated. For example, in the
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Figure 2. (a) ESI-MS spectrum of DMP12-AKDWV-NH2. (b)
ESI-MS2 spectrum of the protonated molecule [MH] atm/z 725
in Figure 2a.
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DWV-NH2, we could easily identify the double peaks at
m/z 725, 731 in Figure 2a corresponding to the proton-
ated molecules of DMP12-AKDWV-NH2, ESI-MS
2 of
the protonated molecule [M  H] at m/z 725 gave b4
(m/z 609), b3 (m/z 423), and b2 (m/z 308) ions (Figure 2b),
and further fragmentation of the b2-ion yielded the
b1-ion at m/z 180. The results gave clear sequence
information for the phosphoramidate peptide.
We also applied DMP132-X to phosphorylate pep-
tides at their N-termini. The protonated molecules of
the monophosphorylated peptides showed triplet
peaks, and the diphosphorylated products and impu-
rity produced multiple and singlet peaks, respectively.
In the case of a DMP132-AKDL-OH peptide, its primary
ESI-MS spectrum (Figure 3a) shows triplet peaks corre-
sponding to the protonated monophosphorylated mol-
ecules at m/z 554, 557, and 560 (abundance ratio1:2:1),
multiple peaks near m/z 668 from diphosphorylated
products, and some singlet peaks including m/z 426,
486, and 588 from impurities. The most intense triplet
peak at m/z 557 yielded an ESI-MS2 spectrum (Figure
3b) showing bn-type ions at m/z 436 (b3), 311 (b2) and
183 (b1), allowing straightforward assignment of the
sequence.
Phosphorylation of Resin-Bound Peptides
and Peptide Sequencing
The resin-bound peptides were also phosphorylated to
give the corresponding phosphoramidate peptides us-
ing a similar procedure and then cleaved from the resin
using TFA (Method B, in the Experimental section).
Compared with the free peptides, the resin-bound pep-
tides only provided monophosphorylated products be-
cause the -amino group on the lysine residue was
protected. For example, the primary ESI-MS spectrum
of DMP-VYKDH-OH showed the base peak at m/z 769
corresponding to the protonated molecule, and ESI-MS2
and MS3 spectra (similar to Figure 1b and c) gave
183.1
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Figure 3. (a) ESI-MS spectrum of DMP132-AKDL-OH. (b) ESI-
MS2 spectrum of the protonated molecule [M  H] at m/z 557 in
Figure 3a.bn-type ions at m/z 614 (b4), 499 (b3), 371 (b2), and 208
(b1), providing the sequence of the phosphoramidate
peptide.
Labeling of Resin-Bound Peptides
Via Phosphorylation and Peptide Sequencing
We used DMP12-X or DMP132-X to label the resin-
bound peptides through N-phosphorylation. The mod-
ified peptides were cleaved by TFA and then also
unambiguously sequenced using similar procedures to
those described above.
Comparison of Unmodified Peptides
and Phosphoramidate Peptides in ESI-MS
We compared ESI-MS spectra of the unmodified pep-
tides and the phosphoramidate peptides. Figure 4
shows the ESI-MS2 spectrum of the peptide VYKDH-
OH. Compared with Figure 1b, Figure 4 exhibits a more
complex spectrum, and only characteristic fragment
ions b4 and b3 were observed. The N-terminal phos-
phorylating method selectively increased the intensities
of bn-type ions relative to other ion types, and the
resulting simplified mass spectra clearly showed se-
quential loss of amino acid residues from the C-termini
of peptides.
Conclusions
The peptides were phosphorylated into the correspond-
ing phosphoramidate peptides, and the electrospray
ionization tandem mass spectrometry of modified pep-
tides provided clear sequence information on the orig-
inal peptides. The protonated partial isotopically-
labeled molecules could be quickly identified in their
primary mass spectra, which could reduce the con-
sumption of sample during mass spectrometric analysis
and improve the veracity of peptide sequencing. The
present method has the following advantages: (1) a
highly efficient and simple derivatization procedure; (2)
selective N-terminal modification during monophos-
phorylation of peptides containing Lys residues; (3)
selective fragmentation on the amide bond to form
series of bn-type ions, so it could be widely applied for
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Figure 4. ESI-MS2 spectrum of the protonated molecule [M 
H] at m/z 661 of VYKDH-OHpeptide sequencing.
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